Carboprost Tromethamine Injection, USP 250 mcg / mL Single-Dose Vial 1 mL (RX)

Carboprost Tromethamine Injection, USP 250 mcg/mL is an FDA-approved, high-potency prostaglandin analogue used by hospitals and healthcare professionals for the treatment of postpartum hemorrhage (PPH) due to uterine atony that has not responded to conventional methods of management, such as oxytocin or ergometrine. Packaged in a convenient single-dose vial (1 mL), this injectable medication delivers rapid and reliable uterine contraction, helping prevent life-threatening blood loss in new mothers.

Fast-Acting Solution for Postpartum Hemorrhage - Trusted by Healthcare Professionals

Uses:

Carboprost Tromethamine Injection USP is indicated for:

• Treatment of postpartum hemorrhage due to uterine atony unresponsive to standard therapies
• Therapeutic abortion between 13–20 weeks of gestation

Clinical Setting: Obstetric emergencies, labor and delivery, gynecology, maternity care

Benefits & Features

• Highest Efficacy in Controlling Postpartum Hemorrhage
• Rapid onset for crucial emergency protocols
• Single-dose vial ensures safe, sterile administration
• Used worldwide in maternity wards and labor & delivery units
• Complies with CDC and ACOG guidelines for PPH management
• Clear concentration: 250 mcg (0.25 mg) in 1 mL

How It Works

Carboprost Tromethamine is a prostaglandin F2α analogue that acts directly on uterine muscle to produce contractions, thereby reducing blood loss and supporting swift recovery after childbirth or abortion procedures.

Side Effects: What To Expect

Most commonly reported side effects include:

• Nausea, vomiting, diarrhea
• Fever, flushing, chills
• Abdominal cramping, pain
• Hypertension, headache
• Rare but serious: bronchospasm, hypersensitivity, anaphylaxis

Always consult your healthcare provider to discuss medical history, potential drug interactions, and risk factors before administering prostaglandin analogues.

CDC Guidelines & Safety Information (2024)

According to the latest CDC and ACOG Practice Bulletins, Carboprost Tromethamine Injection is recommended as a second-line uterotonic agent for the management of postpartum hemorrhage unresponsive to first-line therapies. Adherence to clinical protocols, correct dosing (250 mcg intramuscularly, repeatable every 15–90 minutes to a maximum of 2 mg), and contraindications (e.g., asthma, active cardiac, renal, or hepatic disease) is essential to ensure patient safety.

• Always monitor vital signs and uterine response closely
• Follow hospital protocols for parenteral administration
• Discard any unused medication as per hazardous drug disposal procedures

Note: Not indicated for home use. For hospital or clinic administration by licensed professionals only.

Order Now: Essential for Obstetric Emergency Preparedness

Carboprost Tromethamine Injection, USP, 250 mcg/mL, Single-Dose Vial—the gold standard in advanced obstetric care. Order today to ensure your facility is equipped with the most effective medication for postpartum hemorrhage control!